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ABSTRACT 
Research in multi-attribute decision making and how people adapt strategy 
selection to changes in information suggest an influence of the task environment such as 
increases in task complexity, time pressure, or difficulty.  Decisions made within a health 
context provide similar scenarios in which the environment can affect multi-attribute 
decision making strategies.  This study sought to understand the influence of the 
seriousness and prevalence of a disease on decision outcomes and decision-making 
processes within the context of vaccination.  Twenty-nine participants viewed eight 
hypothetical scenarios involving illnesses reported in the local area or associated with 
travel.  In the scenarios, four illnesses were described that were either low or high in 
terms of the seriousness of the illness as indicated by the symptoms associated with them, 
and the scenarios either described an instance where there was a high or low prevalence 
of the illness in the area.  Participants then used this information to evaluate a matrix 
displaying four possible vaccines as decision alternatives, each with four attributes that 
could be used to determine the benefits of the vaccine or the costs associated with them.  
A mixed-model analysis was used to examine the effects of seriousness and prevalence 
on choice and decision strategy.  The hypothesis that high seriousness and prevalence 
would result in decisions favoring a more effective (and thus, more expensive) vaccine 
was supported.  Additionally, the hypothesis that high seriousness and prevalence would 
lead to participants using strategies that focus on the beneficial attributes was also 
supported.  However, this effect of prevalence was larger than predicted compared to 
seriousness. 
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The purpose of this study was to examine multi-attribute decision making in a 
health context and how contextual changes in a task environment affect decision strategy 
selection and attention allocation.  Contextual changes regarding the health context for 
the study included the seriousness (i.e., symptoms that represent stronger or weaker 
adverse effects on an individual’s health) and prevalence (i.e., the base rate of the disease 
in the population) of an illness.  Twenty-nine participants responded to scenarios by 
choosing among vaccines for diseases varying in seriousness and prevalence. The 
assumption is that more prevalent and serious diseases represent a higher risk to health. 
For each scenario, participants chose one of four vaccines, which varied across four 
attributes related to the vaccine itself (e.g., effectiveness, cost). The research question 
was whether people use adaptive strategy selection for preferential health decisions in 
response to changes in the task environment.  
Theories of Decision Making 
Overview.  When presented with multi-attribute decisions, people can exhibit 
adaptive decision making by using multiple information processing strategies.  Strategies 
are described as adaptive when they produce the most satisfactory outcomes in response 
to limiting factors within the individual or the task environment.  Simon (1955) describes 
rational decision making as being bounded by these limiting factors (e.g., memory 
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retrieval, time constraints) and states that strategies in decision making may be selected in 
order to simplify the decision-making process when needed.  Also, strategy selection may 
be either a conscious, meta-cognitive selection of a strategy as a method of solving a 
problem or a learned unconscious response to a problem.  While these limiting factors 
may influence strategy selection, this study focused on factors related to risk in the task 
environment and how it affected strategy selection.  
Single-Attribute Decisions and Prospect Theory.  Decisions may involve outcomes 
that are certain or uncertain.  In the context of health decision making, a certain outcome 
would include the known monetary cost of a medicine, and an uncertain outcome would 
be the probabilities of certain side-effects one may experience with the medicine. 
Therefore, uncertain outcomes are often expressed using probabilities or frequencies.  An 
uncertain outcome has two or more potential outcomes, only one of which will occur; 
therefore the probabilities of the potential outcomes sum to 1. For example, 4 of every 
100 patients taking drug X will experience side-effect A (and 96 will not). Expected 
utility theory (EUT) and Prospect Theory provide explanations of decision situations 
where multiple decision alternatives are compared on a single attribute (e.g. money won 
or, in the preceding example, getting side-effect A). So in the current example, each 
decision option, if chosen, will result in a single outcome (either getting or not getting 
side-effect A). However, before the decision is made, each option may have multiple 
potential outcomes, e.g., people taking drug X are predicted to have a 30% chance of 
getting side-effect A and a 70% chance of not getting it.  
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EUT was an early attempt to provide an explanation of how individuals ought to 
make these kinds of decisions.  This normative approach states that each decision option 
would result in one or more potential outcomes, and that individuals may value (i.e., 
assign utilities to) the potential outcomes differently. For example, most people will 
assign different utilities to getting vs. not getting side-effect A. Additionally, EUT 
assumes that when people are faced with an uncertain outcome, they weight each of the 
potential outcomes proportionally to the probability of that outcome occurring.  As such, 
each potential decision option would have an expected utility based on the probability 
and utility of the potential outcome; that is, the overall attractiveness of a decision 
alternative (d,p) when the outcome is less than certain is calculated by u(d)*p, where u(d) 
represents the subjective utility of outcome d and p represents the objective probability of 
the outcome occurring.  EUT assumes that people select the decision alternative with the 
highest expected utility. In EUT, a variety of utility functions were used to transform a 
particular objective outcome (e.g., experiencing side-effect A) to a number representing 
the subjective utility of that outcome. 
When people make decisions involving uncertain outcomes, they often do so in a 
way that does not fit with EUT.  Peoples’ internal, subjective interpretations of 
probabilities and the utility of outcomes may fluctuate, even if the probabilities and 
outcomes are stated precisely in objective terms.  Kahneman and Tversky (1979) 
addressed the validity issues with EUT with prospect theory.  Prospect theory suggests 
that when people make decisions involving probabilistic outcomes (prospects), they 
evaluate these outcomes by determining the subjective utility for a potential outcome and 
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a subjective weighting of the probability of that outcome.  In prospect theory, Kahneman 
and Tversky developed a specific utility function (u) for transforming objective 
information about outcomes into subjective utilities. The shape of this utility function 
depends on deviations from the reference point of 0 utility; i.e., the shape differs based on 
whether the utility of outcomes are framed as gains or losses.  For gains relative to a 
reference point, the utility is represented as a concave shape.  For losses relative to a 
reference point, the utility is represented by a convex and steeper shape.  This results in a 
utility function similar to that shown in Figure 1. The different shapes of the utility 
function for gains and losses means that an objective gain of $10 (versus $0 beforehand) 
will yield a smaller change in utility than an objective loss of $10 (versus $0 beforehand). 
 
Figure 1: Kahneman and Tversky’s (1979) proposed S-shaped function. 
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Prospect theory also differs from EUT in how probability information is used.  
According to prospect theory, use of probability information in a decision problem 
depends on subjective transformations of an objective probability rather than the 
objective probability. Kahneman and Tversky (1979) assume a probability transformation 
function (which they call a decision weight function, π(p)) that results in overweighting 
of unlikely outcomes (i.e., small objective probabilities are translated into slightly larger 
subjective decision weights) and underweighting of moderately- and highly-likely 
outcomes (i.e., moderate and large objective probabilities are translated into smaller 
subjective decision weights).  Therefore, translating from objective to subjective 
probabilities does not reflect a linear function as would be used in EUT. 
To illustrate how EUT and prospect theory applies in decision making, I will 
discuss a hypothetical decision task involving health.  Suppose an individual (James) is 
getting a vaccination for the flu season. James is deciding whether or not to take a 
particular vaccine (A) based on a single attribute, the effectiveness of vaccine A in 
preventing flu. Based on information James has gathered, the prevalence of people 
getting the flu is expected to be 10/100.  If James receives Vaccine A, the chance of 
getting the flu drops to 1/100.  It is important to note that it is not necessary to have 
objective information regarding probability to use probabilities as a weight.  Subjective 
assessments of the probability of getting the flu can be made.  Also, in this decision, the 
possibility of getting the flu is not eliminated, therefore the outcome of taking the vaccine 
is less than certain.  James’ assessment of the effectiveness of vaccine A depends on his 
subjective perception of the negative consequences of getting the flu (i.e., the negative 
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utility James assigns to flu) and his subjective perception of the probability of getting the 
flu after receiving vaccine A (i.e., the subjective probability or decision weight James 
assigns to 1/100).   
In EUT, James would maximize expected utility of a decision by calculating the 
weighted sum of the utilities of each potential outcome of each decision option with the 
objective probability of each potential outcome providing this weight, and then selecting 
the action with the maximum expected utility.  In the flu example, if we assume that 
James assigns a subjective negative utility of -100 to getting the flu, then the expected 
utility of not taking the vaccine would be u(d)*p = (-100)*0.10, i.e., the utility is 
multiplied by the objective prevalence. The expected utility of taking the vaccine would 
be (-100)*0.01, i.e., the utility is multiplied by objective probability of getting the flu if 
this vaccine is taken.  The expected utility would be -10 and -1, respectively, therefore in 
order to maximize expected utility James would decide to receive the vaccine.   
To illustrate the predictions of prospect theory for the manipulation of disease 
seriousness in this study, consider two hypothetical situations: One where James is 
deciding whether to take a vaccine for flu or another vaccine for typhoid, where each 
vaccine has an effectiveness such that 1/100 taking the vaccine still get the disease. In 
prospect theory, the calculation of the overall attractiveness of an outcome for a particular 
decision alternative, or overall expected utility, is represented as u(d)*π(p), where u(d) 
and π(p) reflect the non-linear utility and decision-weight functions described earlier.  
With James’ example, the reference point of 0 utility may be his current state of health.  
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This suggests that the assigned numerical utility is dependent on a state that may change 
as his health (and his reference point) changes.  Given that James is healthy now and 
supposing that by some objective measure getting typhoid is three times as bad as getting 
flu, James may subjectively think about typhoid as six times worse than flu, because of 
the steep slope of the utility function for losses.  In prospect theory, objective 
probabilities (p) are transformed based on a mental weighting function (π) that results in 
deviations of subjective from objective probability. However, in this example, the 
objective probability (1/100) does not change for the two decisions, so the subjective 
probability will not change either. Thus, prospect theory predicts that any objective 
difference in seriousness between flu and typhoid will be magnified by the steep slope of 
the utility function for losses.  
EUT and prospect theory reflects single-attribute decisions, and the potential 
outcomes for a single attribute are mutually exclusive.  James is basing his eventual 
decision on the probability of getting the flu, and he either gets the flu that season or does 
not get the flu.  However, most decisions do not involve a single attribute that is 
associated with the alternatives.  The vaccine may have an attribute associated with 
effectiveness, but other attributes that are important to the decision exists as well.  James 
may need to consider the cost of the vaccine, potential side effects, or the availability of 
the vaccine.  These decisions are referred to as multi-attribute decisions.  
 Multi-attribute Decisions.  When faced with a decision involving multiple attributes 
and alternatives, a decision maker may use one of several potential strategies.  Payne, 
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Bettman, and Johnson (1993) argue that these strategies are learned through training and 
experience.  The decision strategy repertoire can be explicitly communicated, as is often 
the case with tools like patient decision aids, or even augmented through the use of 
external aids (e.g., pen and paper notes).  These strategies range from cognitively 
demanding approaches that consider all of the available information to simpler heuristics 
that reduce cognitive effort.  Considering these particular goals in strategy selection, 
Payne (1976) proposed that strategy selection is a process done to minimize cognitive 
effort while satisfying a certain degree of accuracy.   
Previously, I discussed a scenario in which James needed to make a decision 
regarding a flu vaccine.  Suppose that James now has information beyond the 
effectiveness of the vaccine, and knows the cost as well.  Additionally, James has 
multiple vaccines to choose from.  James needs to decide which vaccine to take, and the 
decision problem includes these elements: 
 The vaccines James may select from (decision alternatives). 
 The information that describes different aspects of each vaccine, such as 
effectiveness or out-of-pocket cost (decision attributes). 
  The actual information regarding the magnitude of each potential outcome, 
such as cost in dollars for a particular vaccine (outcomes). 
 James’ subjective assessment of the utility associated with an attribute outcome 
(outcome utility). 
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 James’ subjective assessment of the relative importance of each attribute 
(attribute weight). 
 James’ integration of the importance of the attribute and the utility of a 
particular outcome (weighted utility). 
To elaborate on these elements, I will first refer to a strategy for multi-attribute 
decision making that uses all of these elements, which is called multi-attribute utility 
theory (MAUT) because it elaborates EUT to the multi-attribute situation.  In this 
strategy, James would engage in several steps in order to calculate the overall expected 
utility of each alternative.  Table 1 displays these steps, with each three-row panel (panels 
are separated by black rows) representing information associated with the problem at a 
particular step of using the MAUT strategy. Step 0 shows the initial information 
representing the decision.  In Step 1, James would identify and assign utilities associated 
with each attribute outcome.  These utilities determine the relevance and usefulness of the 
information within the cell.  In Step 2, James would assign weights based on the relative 
importance of each attribute.  This is where James’ personal values and goals can affect 
his overall decision. If he is short on money, he will tend to place a relatively high weight 
on the cost attribute. If he is very concerned about getting ill, he will tend to place a 
relatively high weight on the effectiveness attribute. In Step 3, James would multiply 
each single-attribute utility by the attribute weight to determine the weighted utility for 
that cell (outcome).  In Step 4, the weighted utilities would be summed across all cells 
(outcomes) for a single alternative.  This sum is the overall utility for that alternative. 
These steps would be repeated for each alternative.  As a final step, James would 
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compare these sums to determine which alternative has the best overall utility, which 
would be his final choice. 
 11
 
Table 1. Steps involved in the traditional approach to multi-attribute utility theory. 
Step 0: Initial decision 
information 
Vaccine A (alternative) Vaccine B (alternative) 
Effectiveness (attribute) 1/100 get the flu (outcome) 2/100 get the flu (outcome) 
Cost (attribute) $50 (outcome) $25 (outcome) 
   
Step 1: Assign utilities to 
outcomes 
Vaccine A (A) Vaccine B (B) 
Effectiveness (Eff) Utility for outcome EffA Utility for outcome EffB 
Cost (C) Utility for outcome CA Utility for outcome CB 
   
Step 2: Assign weights to each 
attribute 
Vaccine A (A) Vaccine B (B) 
Effectiveness (Weight of Eff) Utility for outcome EffA Utility for outcome EffB 
Cost (Weight of C) Utility for outcome CA Utility for outcome CB 
   
Step 3: Multiply weight and 
utility to get weighted utility.  
Vaccine A (A) Vaccine B (B) 
Effectiveness (Weight of Eff) (Weight of Eff) * (Utility for 
outcome EffA) 
(Weight of Eff) * (Utility for 
outcome EffB) 
Cost (Weight of C) (Weight of C) * (Utility for 
outcome CA) 
(Weight of C) * (Utility for 
outcome CB) 
   
Step 4: Calculate overall utility 
for each alternative  
Vaccine A (A) Vaccine B (B) 
Effectiveness (Weight of Eff) (Weight of Eff) * (Utility for 
outcome EffA) 
(Weight of Eff) * (Utility for 
outcome EffB) 
Cost (Weight of C) (Weight of C) * (Utility for 
outcome CA) 
(Weight of C) * (Utility for 
outcome CB) 
Overall utility for each 
alternative: 
Weighted utility EffA + 
Weighted utility CA 
Weighted utility EffB + 
Weighted utility CB 
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During Step 1 (determining the utilities for each outcome), it is important to note 
that the process would differ in this example for assignments of utility to effectiveness 
and cost.  With cost, the outcome is certain.  If James chooses Vaccine A, he will have to 
pay $50.  Therefore, the subjective utility of cost is assumed to be based on the objective 
cost information and James’ utility function for cost.  With effectiveness, the outcome is 
uncertain.  If James chooses Vaccine A, there is a less than certain chance of two 
mutually exclusive outcomes.  Either he will get the flu or he will not get the flu.  The 
process for effectiveness involves a sub-step in the strategy, where James must determine 
the overall utility for the cell outcome using prospect theory.  To get the overall cell 
utility for Vaccine A, James would determine the subjective utility of getting the flu 
based on the objective outcome (getting the flu) and his utility function for flu, determine 
the subjective decision weight based on the objective probability of flu and his decision-
weight function for probabilities, and then multiply the subjective utility by the decision 
weight.  Multi-attribute decisions often incorporate attributes that have both certain 
outcomes and uncertain outcomes. 
When using complex decision strategies associated with MAUT, James would 
need to integrate information across attributes for an alternative to determine the overall 
utility for that alternative, and repeat this for every alternative.  However, multi-attribute 
decision making does not necessarily require the use of complex, algorithmic strategies 
like MAUT.  James may choose to incorporate all information before making his decision 
or very little of the information.  Strategies may vary in complexity, use of cognitive or 
attentional resources, and amount of information included in the decision process. 
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An example of a strategy that would use less information would be the 
lexicographic strategy (LEX).  With this strategy, a decision maker would determine 
which attribute would be the most important for accomplishing his goal.  In the example 
provided earlier, perhaps James considered vaccine effectiveness to be the most 
important attribute.  Then each alternative would be compared to find the alternative with 
the highest utility for the effectiveness attribute (i.e., James would determine which 
vaccine was most effective at preventing the flu).  In the strictest definition of the 
lexicographic strategy, no other attributes would factor into the decision.  Choosing an 
alternative based on a single attribute reduces cognitive demand but may not result in a 
decision that would maximize expected utility across all attributes.  For example, James 
may ignore the cost attribute.  Although evaluating a problem based on the attribute you 
find most important can simplify the problem, James may not know the degree to which 
the prices differed.  The cost may be prohibitively expensive for Vaccine A, and provided 
for free for Vaccine B.  If the dispersion of the cost outcomes is high enough, the 
decision-maker might consider switching to a strategy that considers more attributes so 
trade-offs can be addressed (e.g., each alternative is best on one attribute and worst on 
another).  
Some decision strategies may incorporate aspects of both heuristics-based 
strategies and more complex strategies.  One such example would be elimination by 
aspects (EBA).  This strategy begins in a similar fashion as LEX, where the most 
important attribute is identified.  However, a cutoff value for this attribute is also 
determined.  Any alternative that fails to satisfy the cutoff would be eliminated from 
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consideration.  Afterwards, the decision maker would move to the next most important 
attribute and continue the process until one alternative remains.   
Sometimes, decision-makers can combine strategies in a single decision. James 
may begin in a similar fashion as the traditional approach to MAUT.  He may assign 
utilities to outcomes and determine weights for each attribute.  However, before 
calculating weighted utilities or overall utilities, James may decide that he would be 
unwilling to accept a vaccine where 5/100 people who take it still get the flu.  Any 
vaccines with this outcome or higher would be eliminated from consideration entirely.  
Then, after eliminations have occurred, James would evaluate the remaining alternatives 
based on the cost attribute.  At this point, he may determine he is unwilling to pay more 
than $20 and would eliminate vaccines that cost more than this amount.  If this process 
concludes and multiple vaccines remain, James may then use other strategies to evaluate 
the remaining alternatives or pick randomly from the remaining alternatives.   
There are many more strategies that may be used by a decision maker, each 
differing in the amount of information considered for the decision, effort required to use 
the strategy, and the resulting accuracy in the outcome meeting a criterion of importance.  
This trade-off between the cognitive costs and the potential benefits has been identified 
as a contributing factor to how people adaptively change decision strategies in response 
to a task environment (Payne, Bettman, & Johnson, 1993). Thus, it is important to 
understand how the task environment may influence strategy selection. 
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Adaptive Strategy Selection.  When studying adaptive decision making and strategy 
selection, it is important to study variables related to cognitive processes used during 
decision-making in addition to outcomes of decisions.  If only decision outcomes are 
measured, it is difficult to understand why certain task, cognitive, or contextual 
constraints change an individual’s decisions.  For example, a study by Svenson and 
Edland (1987) showed that when participants made decisions regarding renting an 
apartment, the apartment with the lowest rent was chosen more frequently under a strict 
deadline than under a loose deadline, suggesting that the rent attribute value was 
weighted higher under time stress.  When participants were not under a strict deadline, 
preferences reversed; decision outcomes tended to reflect apartments that were more 
expensive, but had a better overall utility when considering other attribute values. 
These findings seem to indicate that elements of the task environment, such as 
time pressure, affect strategy selection.  To examine whether this is true, process 
variables may be observed to provide additional information regarding the frequency and 
duration of evaluating attribute values in a decision problem.  When the task or 
environment is altered in a way that increases cognitive load on a participant, he or she 
may respond by using a less cognitively demanding strategy such as the lexicographic 
rule.  Measuring decision making solely through the outcomes of these decisions is 
insufficient to understanding these strategy shifts. Since the Svenson and Edlund (1987) 
study did not measure process variables, we are not sure about what strategies 
participants actually used. However, many studies have attempted to measure strategy 
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selection in response to changes in a task environment using a combination of process 
and outcome measures. 
Process measures of strategy selection.  A study that identified and measured 
strategy selection was conducted by Payne (1976).  Payne manipulated task complexity 
by varying the number of alternatives and attributes provided in a decision problem.  The 
decision problem involved multiple apartments for rent, where the number of apartments 
(alternatives) was either 2, 6, or 12, and the number of attributes (e.g., rent price, noise 
level) was either 4, 8, or 12.  As the number of alternatives and attributes increased, the 
complexity of the task increased.  Payne’s primary interest was to determine which 
characteristics of a task environment changed strategy selection.  He hypothesized that 
higher task complexity would result in simpler strategies that reduced cognitive load.  He 
used process tracing techniques to understand the strategies used by the participants as 
well as their decision outcomes. 
 The procedure used by Payne involved the presentation of decision alternatives 
and outcomes on an information board, with note cards containing information regarding 
the attribute (e.g., rent) on one side and the outcome value (e.g., $170) on the other.  An 
envelope was displayed on the board for each outcome for each attribute across the 
different apartment choices.  Either 4, 8, or 12 attributes were displayed on the board.  
Therefore, in the condition where 6 alternatives were presented with 4 attributes, 24 
envelopes were presented on the information board.  A card within an envelope had the 
outcome for the attribute and its corresponding alternative written on it.  Process tracing 
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was done by combining two techniques: explicit information search and verbal protocol.  
Information search was measured by recording the order in which cards were selected 
from envelopes of the respective alternatives.  For example, a participant could look at 
the rent outcome for apartment 1, then the commute-distance outcome for apartment 2, 
and so on. The order of outcomes selected provided information regarding whether 
search was conducted within a single attribute but across alternatives or within an 
alternative across attributes, and when shifts between the two occurred.  This method also 
provided information regarding whether certain attributes or alternatives were ignored.  
Verbal protocols were elicited by prompting the participants to “think aloud” as they 
evaluated their selections and how they were using this information to inform their 
decision.  This provided information regarding how a final decision was made and the 
reason for multiple visits to a single outcome. 
 The results from this study confirmed Payne’s hypothesis regarding the increased 
use of simpler heuristics as a function of task complexity.  When the number of 
alternatives or attributes was higher, participants engaged in simpler decision strategies 
such as EBA more frequently.  Verbal protocol indicated explicit statements that certain 
alternatives were being eliminated due to a cutoff not being met by the alternative.  When 
there were two alternatives, participants much more frequently engaged in strategies that 
incorporated more information as suggested by the equal focus of within-attribute and 
within-alternative information processing.   
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 Another study examining the effect of manipulating a task environment on 
strategy selection was conducted by Bettman, Johnson, Luce, and Payne (1993).  In 
contrast to Payne’s (1976) study, participants in this study made gambling decisions that 
allowed for varying degrees of monetary payoff.  Each gamble (decision alternative) had 
outcome information that reflected potential monetary payoffs associated with the 
gamble.  Each of these payoffs had a probability associated with it.  For a simplified 
example, Gamble A may pay either $3, $4, $5, or $6 with respective probabilities of .18, 
.25, .28, and .29.  Therefore, a participant will receive a single payoff as a result of 
choosing Gamble A, and each possible payoff has a specific probability associated with 
it.  Since there was only one attribute for each alternative (amount of payoff), these were 
single-attribute rather than multi-attribute decisions. However, there were multiple 
potential outcomes within the single payoff attribute (i.e., four potential payoffs in the 
above example), so strategies used for multi-attribute decision making could be used. In 
other words, Bettman et al. treated a potential outcome of a gamble as a single decision 
attribute, so that, for the purposes of analysis of strategy use, a single-attribute decision 
was interpreted. They then considered how various multi-attribute decision strategies 
could explain performance on the task. 
Intercorrelational structure was a variable manipulated to have two levels: 
Negatively correlated attribute values (compensatory decisions) and positively correlated 
attribute values (non-compensatory decisions).  Negative correlation structures would 
involve decisions where the attribute values and probabilities involved a tradeoff that 
needed to be made, for example a gamble that had the highest potential payoff may have 
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the lowest probability associated with that payoff.  A competing gamble may have a 
lower payoff, but a higher probability of that payoff happening.  In these situations, no 
single gamble dominates all others in terms of probability or payoff.  In positive 
correlation structures, one gamble dominates on all attributes.  One gamble would have 
the highest payoffs relative to the other gambles, and these payoffs would increase as the 
probability increased.   
Bettman et al. (1993) hypothesized that compensatory decision problems would 
be more likely than non-compensatory problems to produce complex decision strategies 
to maximize potential gains.  In the terminology described by Bettman et al., the strategy 
selected and decision context would be more effortful for complex decision strategies, 
but would also increase accuracy.  When decision problems were non-compensatory, 
certain alternatives dominated others on all attribute (outcome) values and probabilities.  
As such, heuristics could be used to reduce effort while maintaining a satisfactory level 
of accuracy.  Complex strategies would not be necessary to achieve a similar result.   
 Process variables were obtained in a similar fashion to Payne (1976).  Each 
decision problem had four alternatives (gambles), and each gamble had four potential 
outcomes, with each potential outcome consisting of a payoff with its associated 
probability.  All payoffs and probabilities were hidden from the participant.  However, in 
this study a computer-based program was used (MouseLab).  This program allowed for a 
similar interaction as the physical information board, with participants hovering over a 
payoff or probability for an outcome in order to see just that payoff or probability 
temporarily revealed.  Process variables of explicit information search and patterns could 
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be recorded, as well as durations of attribute value views within a cell on a matrix in 
milliseconds.  Thus, process variables were determined by frequency of cell acquisition 
(i.e., views) and the durations of these views.  This computer program automated the 
collection of these variables in a reliable fashion, allowing for more precise behaviors 
regarding decision strategies to be recorded and analyzed.   
 Results regarding decision processes from this study were analyzed using 
durations of cell views to identify whether complex and more effortful strategies were 
being used as opposed to simpler heuristics.  When decision problems involved 
negatively correlated task environments, participants confronted these tradeoff decisions 
in an adaptive fashion: They engaged in more effortful strategies to maximize potential 
gains, including strategies that evaluate all information across all alternatives.  When 
decision problems involved positively correlated task environments, participants chose 
strategies that reduce cognitive effort while maintaining an acceptable level of accuracy 
regarding potential gains.  Again, these results indicate that participants are adaptive in 
strategy selection.  Participants attempt to maximize accuracy in decisions and only 
engage in cognitively demanding strategies when the task environment provided no clear 
dominating alternative. 
Task Environment.  The task environment may influence strategy selection in many 
more ways.  One example includes the initial stage in MAUT of assigning utilities to 
outcomes.  During this process, individuals often determine the importance of an attribute 
regardless of whether they will use complex or simple decisions strategies.  This process 
is dependent on the task environment as well.  Perceptions of the value and probability of 
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an attribute outcome can be affected both by incidental influences and relevant 
information regarding the problem.   
Attribute weights can also be affected by aspects of the task environment.  For 
instance, information displayed simultaneously or separately can affect weighting when 
making decisions related to emotional choices.  Kahneman and Ritov (1994) found that 
when two hypothetical interventions (one involving providing free basic medical 
checkups to farmers, and one involving protecting endangered animals from hunters) 
were presented simultaneously, more weight was given to the intervention that benefits 
people, even if the circumstances were more mundane for that intervention.  When these 
problems were presented separately, and individuals were asked to state how much they 
would be willing to pay to support these interventions, participants were more 
sympathetic to the endangered animal scenario and would allocate more money to this 
intervention to protect them.   These examples highlight how initial judgments of 
attributes in a decision can be influenced by the way in which decision information is 
presented.   
In the current study, participants saw scenarios in a potentially affectively-
charged task environment.  However, the task environment also reflected health decisions 
in which levels of seriousness and prevalence of an illness may influence how 
participants use information regarding alternatives and attributes in decision making. 
Decisions in the health domain.  Adaptive strategy selection can be observed with 
health as the task domain.  However, to discuss how patients may be adaptive in their 
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strategy selection, it is important to identify the contexts in which these decisions would 
be made.  The most relevant example would be a decision involving the selection of a 
treatment (e.g., medication) for an illness. In many health contexts, there are multiple 
potential treatments for an illness.  When patients are gathering information about 
treatments, whether by speaking with physicians, researching on the web, or talking to 
other patients, they are building an array of potential treatment alternatives to consider.   
Alternatives and their associated outcomes are integral in these decisions.  In 
order to evaluate which alternative the patient will pursue, a patient will make predictions 
regarding various effects (outcomes) that the treatment will have.  As mentioned in the 
previous discussion in strategies for single-attribute and multi-attribute decisions, people 
need to evaluate the utility of particular outcomes in order to make an overall decision.  
The patient may consider the following objective information while making a treatment 
decision: How effective a medication is reported to be, how much discomfort is 
associated with a medication’s side effects, how much they will have to alter their routine 
in order to maintain treatment, or several other outcomes.  These predictions are often 
uncertain, which means that they are presented to decision makers probabilistically. In 
this way, attributes and outcomes values reflect information similar to the design used in 
Bettman, Johnson, Luce, and Payne (1993), where particular outcomes are possible when 
making a decision, but are associated with varying probabilities.   
 Finally, as mentioned by Payne et al. (1993), these treatment alternatives all have 
potential utilities that can be perceived as negative or positive, and may often present 
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decision problems reflecting a tradeoff decision where no single alternative dominates all 
other on all attributes.  A treatment may have a high probability of effectiveness, but also 
a high probability of exhibiting unwanted side effects.  The degree to which one 
treatment alternative is preferred to another often depends not solely on probabilistic 
information, but on the patient’s weighting of an attribute.  Similar to the research 
discussed earlier, attribute weights are not necessarily stable and may be influenced by 
manipulations in the task environment.  Even if outcomes remain unchanged for a given 
set of alternatives, it is reasonable to assume that subjective weights may change in 
response to a change in the task environment similar to studies such as Svenson and 
Edland (1987), where time pressures resulted in changes in preference in apartment 
choice.   
 Medical decisions that patients make also can be compensatory or non-
compensatory.  Depending on the value participants place on certain attributes, one 
alternative may or may not dominate others on different attributes.  Multiple aspects of a 
task environment may alter an individual’s strategy selection and use.  These may include 
the source of information gathering (e.g., whether alternatives are gathered from a 
physician or through an individual’s own research), time pressure, or the type of illness 
being treated.  For the current study, I focused on manipulating the seriousness and the 
prevalence of a disease, to understand how these aspects of a task environment affect 
strategy selection and overall decisions.  
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Seriousness of disease and prevalence 
 In this study, I manipulated the type of illness presented in a scenario. The 
different illnesses varied in levels of seriousness (based on descriptions of the diseases 
and associated effects), and the prevalence of the illness in that scenario (based on 
hypothetical announcements regarding illness prevalence).  Seriousness is defined as the 
overall negative impact a disease has on an individual’s health, both in the long term and 
in the short term (i.e., latency before onset of symptoms, severity of symptoms, 
likelihood of hospitalization or long-term complications). Prevalence is defined as the 
base-rate probability of the disease in the immediate vicinity of an individual (i.e., local 
prevalence changes during a localized outbreaks). 
Overview of the Current Study 
 The goal of the present study was to determine what effect seriousness and 
prevalence of an illness may have on participants’ decision processes and choices.  
Seriousness of illness was manipulated by providing scenarios reflecting different 
illnesses with varying severity of symptoms and prognoses, and prevalence was 
manipulated in these scenarios by including information regarding localized outbreaks or 
lack of outbreaks. 
The study presented participants with a multi-attribute decision-making task using 
a modified version of Mouselab (Johnson, Payne, Bettman, & Schkade, 1989).  This 
program provided process and outcome data similar to that found in Bettman, Johnson, 
Luce, and Payne (1993). That is, the outcome for a cell is only visible while the 
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participant hovers over that that cell with the mouse; and the sequence and timing of cell 
visits is recorded. Decision outcomes (choices) were recorded for each decision 
(scenario), and measures of decision processes were based on the durations of visits 
(acquisitions) to individual cells in a decision matrix.   
The study included decision scenarios that varied in seriousness and prevalence of 
diseases.  Seriousness was manipulated by providing information regarding four illnesses 
(i.e., seasonal influenza, mumps, meningitis, and typhoid fever).  As previously stated, 
each of these diseases varies in terms of expressed symptoms and prognosis, some more 
debilitating or potentially fatal than others.  Information regarding negative consequences 
of getting the disease are communicated in textual scenarios provided to participants.  
Results from a pilot survey suggested that influenza and mumps would be comparable 
and low in evaluations of seriousness.  Meningitis and typhoid were roughly equal in 
high evaluations of seriousness.      
Prevalence was manipulated by including information regarding outbreaks in the 
area or by travel to a country where the risk of contracting the disease is higher.  High 
prevalence is indicated by a scenario mentioning that there is an outbreak or large number 
of the local campus population being hospitalized or treated for the disease (i.e., 
influenza, mumps, meningitis) or a hypothetical situation where the participant imagines 
he or she is traveling to a high-risk country for a disease (i.e., typhoid).  Low prevalence 
is indicated by a scenario mentioning there is no concern for an outbreak on campus or 
that the participant would be travelling to a country with low risk of typhoid.  Thus, 
scenarios were presented to participants in a 2 (seriousness high vs. low) x 2 (prevalence 
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high vs. low) within-subjects design. Since there are 2 examples of each level of 
seriousness, this yields 8 scenarios. 
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CHAPTER TWO 
PRESENT STUDY: EVALUATION OF DECISION PROCESS AND OUTCOME IN 
MEDICAL CONTEXT 
 
Research in strategy selection in multi-attribute decision contexts suggests that 
individuals respond to changes in task environments, increased cognitive demand, and 
contextual changes in the decision problem.  In a healthcare context, I argue that the 
concept of subjective utility applies to medical decisions in terms of patients’ (and 
physicians’) evaluations of the general risk of negative or adverse effects associated with 
a disease.  So patients would be expected to assign higher negative utility to a more 
serious illness than a less serious one.  Additionally, I equate the concept of base-rate 
probability of contracting an illness with prevalence.  Base-rate information will not be 
explicitly stated in a numerical form, rather the information will be provided in a manner 
that is more likely to exist in a medical context (e.g., the presence or absence of a local 
outbreak on campus). 
The decisions regarding vaccinations included four alternative vaccines and four 
attributes, as well as the associated outcomes for each alternative.  The outcomes for two 
attributes presented uncertain or probabilistic information (e.g., 2/100 experience side 
effects) and the outcomes for the other two attributes presented certain outcomes (e.g., 
cost of vaccine).  There were two attributes associated with benefits (i.e., strains and 
effectiveness), and two attributes associated with costs (i.e., cost and side effects). In 
addition, in every scenario presented, the two beneficial attributes were always positively 
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correlated with each other and the two cost attributes were always positively correlated 
with each other.  Finally, across the four alternatives, benefits and costs were always 
positively correlated, so that the most beneficial vaccine was the most costly and the least 
beneficial was least costly.  A summary of each attribute is provided in Table 2.  Table 3 
shows the correlational structure of each attribute across the 4 alternatives. 
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Table 2. Attribute information for the present study.  
Attribute information   
Attribute Type of outcome Example 
Effectiveness  Uncertain “1/100 take the vaccine and still get the 
flu” 
 
Strains protected  Certain  “Vaccine protects against 4 strains of 
the virus” 
 
Side effects  Uncertain “4/100 experience mild side effects 
from the vaccine” 
 
Out of pocket Cost  Certain “$20 out of pocket cost” 
 
Table 3.  Example problem showing correlational structure of vaccine alternatives for the 
present study.  
 Vaccine 1 Vaccine 2 Vaccine 3 Vaccine 4 
Effectiveness 1/100 still get flu 
++++ 
2/100 still get flu 
+++ 
3/100 still get flu 
++ 
4/100 still get flu 
+ 








Side Effects 8/100 have side 
effects 
+ 
6/100 have side 
effects 
++ 
4/100 have side 
effects 
+++ 
2/100 have side 
effects  
++++ 










Note. + refers to levels of utility of outcome, with ++++ being the highest and + being 
the lowest. The pluses were not present in the problems shown to participants. 
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Hypotheses Regarding Seriousness. I hypothesized that as the scenarios change 
from low to high seriousness, people will increase the amount of time attending to 
effectiveness and strains, and decrease the amount of time attending to cost and side 
effects.   
In addition to this quantitative hypothesis regarding shifts in attention allocation, I 
also assessed strategies associated with the attention shifts. With high seriousness being 
reflected in high negative utility, process data may indicate an increase in strategies that 
reflect the lexicographic (LEX) method with effectiveness and/or strains being the most 
important attribute(s).  With low seriousness, effectiveness attributes may become less 
important due to the decrease in negative utility associated with the type of illness. 
Therefore, weights may begin to become more even across attributes.  The decision 
problem then becomes one in which the strategy may not be to choose the most effective 
alternative, but to choose an alternative that satisfies other criteria as well.  Therefore, 
decision processes would reflect strategies such as EBA.  Participants may still consider 
effectiveness to be the most important attribute, but they no longer simply make their 
decision based on a single attribute, as when LEX is used with the effectiveness attribute.  
They would eliminate alternatives that do not meet certain requirements for effectiveness, 
and then move to the next most important attribute (e.g., cost).  Then, a decision would 
be made whether any of the remaining alternatives should be eliminated due to an 
undesirable cost. 
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Finally, I hypothesized that as diseases change from low to high seriousness, 
vaccine choices would shift towards vaccines that are optimal in terms of the 
effectiveness attribute (i.e, vaccines with the lowest probability of getting the disease) or 
the strains attribute, which has a correlation of +1.0 with effectiveness.  With low disease 
seriousness, participants were expected to more often choose a vaccine that balances 
effectiveness and cost attributes, which would result in a choice in between the most 
effective and highest cost vaccine and the least effective and lowest cost vaccine. With 
high seriousness, participants are expected to base their choice mainly on the 
effectiveness attribute, thus leading to more choices of the most effective and highest cost 
vaccine 
The rationale for these predictions was that, as the illness increases in perceived 
losses in relation to an individual’s health (i.e., in seriousness), people should give more 
weight to attributes related to the individual’s best chance of avoiding those losses.  From 
the perspective of MAUT, an increase in the seriousness of an illness should lead people 
to assign greater attribute weights for effectiveness and strains.  However, an increase of 
seriousness should not be associated with increased attribute weights for costs or side 
effects.  As such, for scenarios where there is a higher potential to experience serious 
symptoms, the most important attribute would be identified as effectiveness of the 
vaccine or how many strains it protects against (which have a correlation of +1.0).  
Process data would reflect this with higher percentages of time dedicated to visits to these 
two attributes.  In the LEX method, the alternative would be determined by the attribute 
with the highest chance of being effective at preventing the illness. 
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Hypotheses Regarding Prevalence. I hypothesized that as the scenarios change from 
low to high prevalence, people will increase the amount of time attending to effectiveness 
and strains, and decrease the amount of time attending to cost and side effects.   
Similar to the effects of seriousness, I predicted that increasing prevalence may 
result in an increase in the use of the LEX strategy.  When a disease increases in 
prevalence, participants may spend more time evaluating benefits (i.e., effectiveness and 
strains) of the vaccine relative to the costs.  As prevalence decreases, time may be more 
evenly distributed among the benefits and the costs, suggesting an EQW strategy.   
Finally, I hypothesize that as diseases change from low to high prevalence, 
vaccine choices (overall decision outcomes) will shift towards vaccines that are optimal 
in terms of the effectiveness attribute (i.e, vaccines with the lowest probability of getting 
the disease) or the strains attribute, which is has a correlation of +1.0 with effectiveness. 
The rationale for predicting that increasing disease prevalence will lead to these 
shifts in attention allocation, strategies and vaccine choice is the same as for the 
seriousness hypotheses. That, as the illness increases in perceived risk to an individual’s 
health (i.e., in prevalence), people should give more weight to attributes related to the 
individual’s best chance of avoiding this risk (i.e., to the effectiveness and strains 
attributes).  However, an increase of prevalence should not be associated with increased 
attribute weights for costs or side effects.  The increased weight given to effectiveness 
and strains will be associated with increased attention to these attributes and to choices 





Participants were 29 (17 female, 12 male) undergraduate adults recruited from 
Clemson University.  Participants were assigned to all combinations of levels of 
seriousness and prevalence of diseases.  
A power analysis was conducted using the software application G*power that 
reflected a conservative estimation for repeated measures ANOVA with interaction.  The 
sample size was calculated assuming a Cohen’s d effect size of 0.25.  Using the output 
from this power analysis, the number of participants deemed necessary was 24, including 
the 4 levels of seriousness and 2 levels of prevalence repeated within subjects. To 
facilitate detecting effect sizes smaller than 0.25, we set a goal of 30 participants prior to 
data collection. 
Design 
The study was a 4 (disease type: influenza[F], meningitis[Men], mumps[Mu], 
typhoid[Typ]) x 2 (prevalence: high, low) within-subjects design.  In total, 8 decision 
problems involving vaccinations were presented to each participant.   
The quantitative dependent measures were decision outcomes, (i.e., vaccine 
choices), and decision processes, (i.e., time attending to particular attributes).  Vaccine 
choice had four levels: the vaccine that represents the highest benefits and costs, second 
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highest benefits and costs, third highest benefits and costs, and lowest benefits and costs. 
(Remember that across alternatives, high benefits are always associated with high costs, 
and vice versa.)  
Qualitative variables describing decision-making strategies were coded from the 
Mouselab data on the sequence, frequency and duration of visits to cells of the decision 
matrix during each problem. In some analyses, the strategy variables were dependent 
variables and prevalence and seriousness were the independent variables.  
Materials and Tasks 
Disease seriousness and prevalence were manipulated in these scenarios by mock 
news articles regarding the disease.  These news articles were presented to the 
participant, along with a headline detailing synopsis of the illness and its prevalence.  The 
participants also read the article below the headline detailing the specifics of the illness 
and prevalence. These details were designed to manipulate the participants’ impression of 
the seriousness of the illness. After reading the scenario, participants responded to a 
comprehension question about the topic of the preceding article in order to determine if 
the article was read and that the participants were considering the illnesses and 
prevalence when making a decision regarding a vaccine. The example scenarios for each 
level of prevalence and seriousness are included in Appendix A. 
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Figure 2: Sample scenario (Flu / high prevalence) article. 
Equipment. Participants used a modified version of Mouselab on desktop 
computers for all aspects of the study.  Participants used computers for the entire duration 
of the study, and did not be have the option of using any external aids. 
36
Questionnaires.  Participants provided demographic information at the beginning 
of the experiment.  In addition, participants reported their typical compliance with 
immunizations.  This survey was given at the conclusion of the study. This compliance 
survey was added due to responses from an initial pilot test in which some participants 
stated that they would have chosen not to take a vaccination if that had been a possible 
choice.  Therefore, the inclusion of this question was to determine if participants’ 
responses were affected by their beliefs about vaccinations. 
A manipulation check was conducted to determine whether the seriousness 
manipulation was sufficient, and whether the chosen example illnesses of flu and the 
mumps were interpreted as lower seriousness compared to meningitis and typhoid fever. 
This check was conducted at the conclusion of the study in the form of 8 questions 
regarding each illness.  The list of specific questions can be found in Appendix C. 
Additionally, the conclusion of the study included a questionnaire to assess 
awareness of the manipulation or hypothesis, as well as a 20-item inventory measuring 
risk-taking in health and safety with the inclusion of the medical risk-taking subscale 
from the Domain-Specific Risk Taking (DOSPERT) Inventory (Blais, & Weber, 2006; 
Butler, Rosman, & Seleski, 2012).  The DOSPERT was given to determine if there were 
any individual differences associated with risk-taking behaviors that may have 
contributed to a participant’s decisions regarding vaccinations. 
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Procedure 
An experimental session overall lasted approximately 30 minutes.  The participant 
read an information letter including basic information about psychological research.    
Then the experimenter provided training for the participant in the form of a decision-
making task in the same format as the experimental condition, but using a topic 
associated with online shopping rather than a health decision scenario.  Then the 
participant practiced on a second similar decision-making task.  The experimenter 
informed the participant that the selection of a vaccine was necessary for each scenario, 
but information about each vaccine was hidden behind each cell on the page, and in order 
to view information that may be helpful in making a decision, the participant would need 
to move the mouse cursor over each cell to reveal the information.   
At the beginning of the experimental session, the Mouselab program randomly 
displayed an illness type within one of the two blocks.  One block included all low 
prevalence scenarios, and the other block included all high prevalence scenarios.  Every 
scenario began with the mock news article shown in Figure 4 detailing the illness and 
prevalence, followed by a short comprehension question regarding the topic of the article. 
After moving past these two pages, the multi-attribute decision matrix with the four 
vaccine alternatives and attributes were displayed.  Refer to Figure 5 for an example.  
The order of the vaccines and attributes on each scenario was randomized, and the 
vaccine names differed depending on the illness.  Each name provided no clues of the 
quality of the drug, and names were fabricated with the intention of reducing bias or 
38
name recognition across trials.  Additionally, the attribute information was displayed in 
each scenario so the participant could read more detailed information about the definition 
of each of the four attributes by hovering over those attribute names.  Cell views and time 
were recorded when participants interacted with cells in the matrix.  A summary 
description of the article from the previous page was displayed at the top of the window 
as a reminder of the relevant information for the current decision task (see Figure 5). The 
text emphasized the values of the independent variables for the current scenario in bold 
(seriousness and prevalence). 
Figure 3: Sample multi-attribute decision matrix.  Each cell has information 
regarding the outcome hidden.  Moving the cursor over a cell reveals this 
information, and records process data. 
After the decision was made and confirmed, participants repeated the process 7 
more times, with a break between blocks.  At the conclusion of the decision-making 
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RESULTS AND DISCUSSION 
Manipulation Check 
To use the four illnesses adequately manipulated participant’s perceptions about 
disease seriousness, a manipulation check was conducted based on two post-test 
questions. For each of the four diseases, participants were asked “how afraid” they were 
of getting the disease and “how bad it would be (in terms of debilitation, amount of time 
spent in recovery, and risk to long-term health)” if they were diagnosed with the disease. 
Participants responded using Likert scales ranging from 1 to 7, with 1 represented less 
fear or concern associated with the illness while 7 represented high fear or concern of the 
illness and its effects. We averaged participants’ responses to these questions to estimate 
their perceived seriousness for each disease. Participants perceived the flu and mumps as 
less serious, mean rating of 3.57 (SD = 0.92) and meningitis and typhoid fever as more 
serious, mean rating of 5.34 (SD = 1.09). This difference was significant, t(56) = 1.77, p 
< .001.  This represented a large effect size, Cohen’s d = 1.75. Thus, the four diseases 
adequately manipulated perceived seriousness. 
Predicting choice by prevalence and seriousness of disease. 
After data collection, it was found that one participant viewed one of the 
combinations of prevalence and seriousness twice due to a computer error, therefore this 
participant’s data were not included in the final analyses.  The independent variables in 
this study were seriousness of disease and prevalence. The dependent variable measure 
was vaccine choice, coded as a variable ranging from 1 to 4.  A response of 4 reflects the 
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decision alternative that is highest in effectiveness, and a response of 1 reflects the 
alternative that is lowest in effectiveness. This analysis assesses whether changes in 
seriousness or prevalence affected whether participants were more likely to choose a 
more effective option. For the analysis, decision outcomes were recorded as ranging from 
the vaccine with the highest benefits and costs (choice value of 4) to the vaccine with the 
lowest benefits and costs (1). The hypotheses were that as seriousness and prevalence of 
the disease increased, the vaccine with maximum benefits would be more likely to be 
chosen despite its high costs, resulting in choice responses closer to 4 rather than 1. When 
seriousness and prevalence were low, it was expected that participants would focus less 
on benefits and more on costs (or on both), which would lead to choosing vaccines that 
were not maximally effective but had lower costs.  
A mixed-model analysis was run using the SPSS Mixed Model Analysis 
procedure. These models incorporated both independent variables of seriousness and 
prevalence as fixed variables. Effect sizes were calculated using R2. Starting with the null 
model, hierarchical regression models added one variable at a time and R2 was calculated 
based on the difference of residuals in the current and prior models. Cohen’s (1992) 
standards whereby R2 of .01, .06, and .15 represents small, medium, and large effect 
sizes, respectively, were used for interpretation. 
Figure 6 shows the effect of prevalence and seriousness on participant’s choices. 
The mean choice increased from 2.09 (SD = 1.09) when prevalence was low to 3.31 (SD 
= 0.89) when prevalence was high. This effect was significant, F(1,1) = 54.190, p = .000. 
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The mean choice increased from 2.47 (SD = 1.17) for low seriousness to 2.92 (SD = 1.12) 
for high seriousness, suggesting the predicted main effect. This effect was significant, 
F(1,1) = 27.542, p = .000. These two main effects support the hypothesis that higher 
levels of seriousness and prevalence of illness would lead to participants weighting 
benefits over costs and thus choosing vaccines that were higher in effectiveness. Finally, 
there was no significant interaction between prevalence and seriousness, F(1,1) = 2.079, 
p = .152.    
By comparing a prevalence only model with the null model, R2 = 0.402, 
suggesting a large effect size for prevalence. When seriousness was added to the 
prevalence model, R2 = 0.054, suggesting a medium effect size for seriousness.  Thus, 
although prevalence and seriousness showed the predicted main effects, the prevalence 
effect was much larger than the seriousness effect, contrary to predictions.  
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Figure 4.  Prevalence and seriousness of illness plotted as a function of 
vaccine choice ranging from lowest in effectiveness and cost (1) to highest 
effectiveness and cost (4).  The mean response for vaccine choice for each 
strategy at each level of prevalence and seriousness for benefits-focused (B), 
equal-weighting (E), and cost-focused (C). 
Calculation of process variables 
Decision-making strategies were measured using Mouselab data on how 
frequently participants visited cells within the decision matrix time and the sequence and 
duration of cell visits. These measures allowed for the testing of the hypotheses regarding 
how varying seriousness or prevalence affected strategy use. The strategy analysis 
focused on identifying when participants were using decision-making strategies that 
involved scanning within attributes (e.g., lexicographic) vs. within alternatives (e.g., 
satisficing) and, if they were scanning within attributes, whether they prioritized certain 
attributes or considered all of the attributes more equally. When recording the measure 
associated with duration of within-attribute visits, any durations less than 200 ms for a 
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single cell view were dropped from analysis, as this short duration could be reasonably 
interpreted as cursor movement over cells without intention to read (Johnson, Payne, 
Schkade, Bettman, 1989). 
A visit to a particular attribute was coded when a participant sequentially revealed 
cells within that attribute without revealing cells outside of the attribute. The rationale 
was that participants revealing information regarding a single attribute across alternatives 
were making comparisons within that attribute. The identity of the attribute was recorded 
along with the duration of the visit. This allowed calculating the number and duration of 
visits to particular attributes. An analogous process was used to calculate number and 
duration of visits to each alternative.   
Initially, process data were used to determine to what degree participants viewed 
information within attribute compared to within alternative.  This was calculated by 
adapting the Search Index (SI) formula from Payne (1976). The SI is determined by the 
duration of viewing within alternatives compared to the duration viewing within 
attributes, as indicated by the following ratio. 
 (1) 
The index ranges from -1.00 to 1.00, indicating a complete attribute focus to a 
complete alternative focus, respectively.  The mean SI for participants in this study was 
-0.271 (SD = 0.461), suggesting that participants engaged in within-attribute comparison
of information more than within-alternative comparison.  Therefore, the primary analysis 
of the effects of prevalence and seriousness on strategy selection focused on evaluations 
of within-attribute strategies, e.g., lexicographic vs. equal-weighting.  
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In order to test the hypothesis regarding whether participants were evaluating all 
attributes with equal weight or giving different weights to attributes related to benefits 
(vaccine effectiveness; strains) or costs (side-effects; out-of-pocket price) of the vaccine, 
the following process variable was calculated for each decision problem a participant 
completed. 
(2) 
where Tbenefits and Tcosts represented the duration spent visiting the two benefits 
attributes and the two cost attributes, respectively.  
TimeATT describes whether a participant focuses on benefit vs. cost attributes. 
The values of TimeATT range from -1 to 1.  A value of -1 means that for a particular 
problem, the participant only compared attributes associated with costs, and never did 
any within-attribute comparisons for benefits, whereas a value of 1 means that the 
participant only engaged in within-attribute comparisons for benefits. In both of these 
cases, the strategies match the lexicographic decision-making strategy, where an attribute 
is determined to be the highest priority and therefore the individual only looks at that 
specific attribute. Figure 7 shows the distribution of the 232 problems in terms of 
TimeATT. This variable has a mean near 0 (-.06) and a large SD (0.63). The variability is 
large because participants focused exclusively on costs for 41 problems, and on benefits 
for 31 problems.  
I identified two codes for the lexicographic strategy, depending on whether the 
vaccines’ benefits or costs are the most important. When TimeATT is near 0, the 
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participant is dedicating roughly equal attention to costs and benefits. For the purpose of 
this study, a participant was deemed to weight benefits and costs on a problem 
approximately equally (EQW) when TimeATT was between -.25 to .25.  Any values that 
were between -1 and -.25 were coded as a cost-focused strategy (COST), and values 







Figure 5. Histogram for TimeATT 
Prevalence and seriousness of illness and decision-making strategy 
I hypothesized that higher seriousness and prevalence would be associated with 
an increased use of the lexicographic strategy with the participants identifying the benefit 
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attributes as the most important attributes.  When illnesses were low in prevalence and 
seriousness, I predicted that participants would engage in a strategy more similar to 
EQW, where they generally give equal attention to benefits and costs.   
Table 3 shows the frequency of using each strategy for the four combinations of 
prevalence and seriousness averaged across all participants. The problems where 
prevalence and seriousness were both high or were both low provide the clearest test of 
the hypotheses. When prevalence and seriousness were both high, participants seemed to 
use the benefits strategy more than EQW, as predicted, and also more than the costs 
strategy. When prevalence and seriousness were both low, participants used the benefits 
strategy less and instead used the EQW strategy more, as predicted, or the costs strategy. 
I did not predict that participants would focus strongly on costs on these problems. 
However, this finding is consistent with the idea that when avoiding the negative utility 
of contracting a disease is less important, participants do not need to focus as much on 
beneficial attributes that allow avoiding the disease. Thus, the cost-focused and the EQW 
strategy are similar in that both are plausible ways to weight attributes when focusing on 
benefits is not required.  
 A multilevel-model analysis was run using the SPSS Mixed Model Analysis 
procedure, with the strategy used as the dependent variable and prevalence and 
seriousness as the fixed variables. Using strategy selection as a dependent variable, a 
value of 3 represents a benefits-focused strategy, 2 represents an EQW strategy, and 1 
represents a cost-focused strategy.  Starting with the null model, hierarchical regression 
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models added one variable at a time and R2 was calculated based on the difference of 
residuals in the current and prior models.  
Figure 6 shows that the mean strategy selected changed from 1.76 (SD = 0.812) 
when prevalence was low to 2.21 (SD = 0.825) when prevalence was high, suggesting 
that participants favored a benefits-focused strategy more when prevalence was high and 
a cost strategy more when prevalence was low. This effect was significant, F(1,1) = 
9.741, p = .004.  By comparing a prevalence only model with the null model, R2 = 0.073, 
suggesting a moderate effect size for prevalence. The mean choice was 1.964 (SD = 
0.825) for low seriousness, and 2.005 (SD = 0.812) for high seriousness, indicating no 
main effect of seriousness, F(1,1) = 0.029, p = .866. The main effect of prevalence 
supports the hypothesis that higher levels prevalence of illness would lead to participants 
using a lexicographic strategy that focuses on benefits.  However, the lack of a main 
effect of seriousness of illness does not match my hypothesis that seriousness would have 
a similar effect on strategy selection. Finally, there was no significant interaction between 
prevalence and seriousness, F(1,1) = 0.618, p = .435.    
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Figure 6. Seriousness and prevalence by strategy selection for cost-focused strategies 
(1), EQW (2) and benefits-focused strategies (3). Error bars represent standard 
deviations. 
In addition, the model above was run with the strategy selection dependent 
variable represented by a dichotomous variable of whether participants chose a benefits-
focused strategy or not. The same tests were applied and found the same results regarding 
effect sizes and significance. The three-level variable provided more precision in 
describing how participants allocated attention to different attributes; therefore, this 
variable was used to frame the results of this portion of the study. 
50
Table 4: Average per problem percentage of strategy use by the level of prevalence and 
seriousness of the illness. SD’s are in parentheses. Of the 232 decisions made by the 29 
participants, 3 decisions were dropped due to matching an alternative-based processing 
strategy (satisficing). This is why the percentages do not sum to 100 for some of the four 
problem types.  
Prevalence 
Low High 
Seriousness Low High Low High 
Benefits 24.1 (36.9) 22.4 (31.6) 41.4 (44.4) 50.0 (40.1) 
EQW 31.0 (33.9) 25.9 (31.7) 29.3 (39.0) 25.9 (31.7) 
Costs 43.1 (34.7) 51.7 (36.6) 29.3 (41.2) 20.7 (34.1) 
How decision-making strategy affects choice. 
I had no original hypothesis on how decision-making strategy would specifically 
affect vaccine choice, as my primary hypotheses were related to how the manipulation of 
seriousness and prevalence would influence strategy use and whether participants chose 
vaccines that were more effective based on these manipulations. However, in an 
exploratory analysis, I investigated whether using the benefits, EQW or costs strategy 
affected choice. Strategy use is an observed variable that was shown in the previous 
analyses to be correlated with prevalence and seriousness. Therefore, one cannot test 
whether strategy use predicts choice outside of the context of prevalence and seriousness. 
Because of this, strategy use was added as a predictor to the best multilevel model where 
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prevalence and seriousness predicted choice (i.e., prevalence and seriousness as main 
effects).  
Figure 6 shows the relationship between strategy use and vaccine choice for the 
four combinations of prevalence and seriousness.  Using the benefits strategy resulted in 
vaccine choices closer to maximum effectiveness, while a costs-focused strategy resulted 
in choices that minimized effectiveness but also costs.  In the model with prevalence, 
seriousness and strategy use as predictors of choice, there was a significant effect of 
strategy use, F(1,1) = 6.02, p = .018, and R2 = 0.015, indicating a small effect size, and 
prevalence, p < .001, and seriousness, p < .001, remained significant. 
Individual Differences in Strategy Use 
Results from this study have shown an overall effect of seriousness and 
prevalence on vaccine choice, as well as some indication that seriousness and prevalence 
influence strategy selection when considered on average across participants.  However, it 
is also important to examine how each participant responded to changes in prevalence 
and seriousness, and whether participants on an individual level engaged in adaptive 
decision-making based on changes in prevalence and seriousness. This section focuses on 
individual differences regarding strategy use across each level of prevalence and 
seriousness.   
Table 4 shows the proportion of problems where each participant used a benefits-
focused strategy, a costs-focused strategy, or an EQW strategy for each four 
combinations of prevalence and seriousness.  The participants are reordered in this table 
to group them in four distinct patterns of adaptation to the changing scenarios.   
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Table 4: Proportion of strategies used across four combinations of prevalence and 
seriousness per participant.  Participants are grouped based on similar patterns regarding 
how they adapt to the changes in prevalence and seriousness.  
Low Prev. / Low 
Ser. 
Low Prev. / High 
Ser. 
High Prev. / Low 
Ser. 
High Prev. / High 
Ser. 
ID Ben Cost EQW Ben Cost EQW Ben Cost EQW Ben Cost EQW 
Group 1 – strongly fits hypothesis 
1 0 0.5 0.5 0 0.5 0.5 1 0 0 1 0 0 
2 0 0.5 0.5 0.5 0 0.5 1 0 0 1 0 0 
20 0 0.5 0.5 0 1 0 1 0 0 1 0 0 
22 0 0.5 0 0 1 0 1 0 0 1 0 0 
4 0 0 1 0 0.5 0.5 0 0.5 0.5 1 0 0 
5 0 0 1 0 1 0 0 0.5 0.5 1 0 0 
Group 2 – partly fits hypothesis 
21 0.5 0 0.5 0.5 0.5 0 0 1 0 1 0 0 
25 0.5 0.5 0 0.5 0.5 0 0 1 0 1 0 0 
29 0.5 0.5 0 0.5 0.5 0 1 0 0 1 0 0 
7 0 0 1 0.5 0 0.5 0 0 1 0.5 0 0.5 
13 0 1 0 0.5 0.5 0 1 0 0 0.5 0 0.5 
27 0 1 0 0.5 0.5 0 1 0 0 0.5 0 0.5 
18 0 0.5 0.5 0 0 1 1 0 0 0.5 0.5 0 
15 0 0.5 0.5 0 0.5 0.5 0.5 0 0.5 0.5 0.5 0 
10 0 0.5 0.5 0 0 1 0 0 1 0.5 0 0.5 
6 0 0.5 0.5 0 0.5 0.5 0 1 0 0.5 0 0 
Group 3 – partly opposite of hypothesis 
9 1 0 0 0.5 0.5 0 0 0 1 0.5 0 0.5 
24 1 0 0 0 0.5 0.5 0.5 0.5 0 0.5 0 0.5 
28 1 0 0 0 0.5 0.5 1 0 0 0.5 0.5 0 
23 1 0 0 0 1 0 0.5 0.5 0 0 1 0 
16 0.5 0 0.5 1 0 0 0 0 1 0 0 1 
8 0 0.5 0.5 0.5 0 0.5 0.5 0 0.5 0 0 0.5 
17 0.5 0.5 0 0 1 0 0 0 1 0 0.5 0.5 
12 0 1 0 0 1 0 0.5 0 0.5 0 0 1 
Group 4 – never focused on benefits 
3 0 0.5 0.5 0 0.5 0.5 0 1 0 0 0.5 0.5 
14 0 1 0 0 0.5 0.5 0 1 0 0 1 0 
26 0 0.5 0.5 0 1 0 0 1 0 0 1 0 
11 0 1 0 0 1 0 0 0.5 0.5 0 0.5 0.5 
Group 5 - unclassified 
19 0.5 0.5 0 1 0 0 0.5 0 0.5 0.5 0 0.5 
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Group 1 includes six participants who always engaged in a benefits-focused 
strategy when both prevalence and seriousness were high. When both prevalence and 
seriousness are low, these participants engage in a combination of cost-based strategies 
and EQW, but never show a benefits-focus. These participants most closely match my 
hypotheses that an increase in seriousness and prevalence would be accompanied by a 
shift in strategy to focus on attributes that involve the effectiveness of the vaccine, i.e., 
benefits.  
Group 2 consists of 10 participants who partially supported the hypothesis, but 
less strongly than Group 1. This generally means that the participant at least once used a 
benefits-focused strategy when viewing a high prevalence and seriousness scenario, and 
may or may not have used a benefits-focused strategy when making a decision in a low 
prevalence and seriousness scenario.   
Group 3 includes eight participants who engaged in behaviors that were opposite 
what I predicted in my hypothesis regarding strategy selection. These participants either 
never used a benefits-focused strategy when prevalence and seriousness were high, 
always used benefits strategies when prevalence and seriousness were low, or both.   
Group 4 includes four participants who never used a benefits-focused strategy 
when choosing a vaccine, regardless of the prevalence and seriousness associated with 
the scenario. These participants also did not support the hypothesis that participants 
would focus on benefits when prevalence or seriousness were high. Group 5 consists of 1 
unclassified participant.   
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These notable differences between the strategy selection associated with the three 
groups could help explain why the hypothesis that prevalence and seriousness affects 
strategy selection only provided a few simple-effects associated with the use of benefits-
focused strategies when prevalence and seriousness was high. The individual differences 
indicate generally that participants changed decision-making strategies across the eight 
scenarios, but in a manner that only sometimes matched the hypothesized strategy 
selections.   
Risk Taking and Strategy Use. The DOSPERT survey of health risk taking was 
included to further investigate what potential effects individual differences may have had 
on the results. High DOSPERT scores indicated greater aversion to health-related risk 
taking. The responses on the survey for each participant were correlated with overall 
proportion of strategy use. There was a positive correlation between the DOSPERT score 
and of the frequency (proportion) of using a benefits-focused strategy, r(27) = .512, p = 
.005, and a negative correlation between the DOSPERT score and the average use of 
costs-focused strategy, r(27) = -.571, p = .001.  These correlations suggest that 
participants who were more risk-averse regarding their health were more likely to focus 
on benefits of the vaccines and disregard costs.  There was no correlation between the 
DOSPERT score and the EQW strategy, r(27) = .121, p = .533. 
These results of the DOSPERT inventory may provide an additional explanation 
for why certain groups in Table 4 seemed to respond to the tasks in the study in a 
consistent fashion. As indicated by Group 4, some participants never incorporated a 
benefits-focused strategy in their decision making regarding the scenarios provided. The 
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results from the DOSPERT analysis suggests that individual comfort regarding health 
risk-taking may influence strategy use and decisions more so than variances in prevalence 




The purpose of this study was to examine multi-attribute decision making and 
how contextual changes in a health-based task environment affect decision strategy 
selection and choice.  Figure 7 summarizes the findings regarding how the prevalence 
and seriousness manipulations affected strategy selection and choice. I hypothesized that 
as prevalence and seriousness increased, vaccine choices would be higher in benefits, 
represented in Analysis 1.  Secondly, I hypothesized that as prevalence and seriousness 
increased, participants would use lexicographic strategies that focus on the attributes 
associated with benefits more than costs. Additionally, I hypothesized that lower 
prevalence and seriousness would be associated with equal weighting across all 
attributes. These two hypotheses were tested in Analysis 2.  Finally, I had no specific 
hypotheses regarding the relationship between strategy selection and choice, represented 
in Analysis 3. 
As indicated in Figure 7, Analysis 1 showed a large effect of prevalence on 
choice, and a moderate effect of seriousness on choice in the direction hypothesized.  
Analysis 2 showed that that prevalence had a moderate effect on strategy selection, in 
that higher prevalence was associated with strategies that focused on benefits and not 
costs.  Finally, Analysis 3 showed that there was a small effect of strategy selection on 
choice, such that strategies that emphasized benefits were associated with choices of 
vaccines that maximized benefits while increasing costs.  Overall, my hypotheses were 
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supported, with the exception of the low effect size of prevalence and the lack of an 
effect of seriousness on strategy selection. 
Figure 7. Illustration of the three analyses conducted in the study. 
Only significant effects are shown. 
Factors that affect objective and subjective health risks 
This section discusses the independent variables manipulated in this study, the 
efforts made to ensure the strength of the manipulation of the levels of the variables, and 
the extent to which this was successful. 
Seriousness and prevalence of disease.  Seriousness and prevalence of disease 
were manipulated in this study to provide differences associated with health risks in 
regard to the magnitude of the negative utility and the probability, respectively. There 
were no specific predictions regarding the difference of effect size associated with these 
two manipulations.   
As prevalence and seriousness of a disease increased, participants were 
significantly more likely to make a choice that maximized effectiveness but also 
increased costs. However, the effect size was much stronger for prevalence than strength. 
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In other words, the likelihood of experiencing the negative utility associated with the 
disease seems to affect decision making more than the magnitude of the negative utility. 
When considering the reasons for this difference, it should be noted that the four diseases 
intended to manipulate perceived seriousness actually did so (d = 1.75 for the difference 
between seriousness ratings of the nominally low- vs. high-seriousness diseases). The 
difference in effect size associated with prevalence and seriousness could be due to the 
nature of losses resulting in a larger change in utility than gains. Each of the four diseases 
used to manipulate the degree of seriousness may have been interpreted by participants as 
having objectively different symptoms that reflect differing degrees of negative utility, 
but each of those diseases would still be associated with some degree of perceived loss.  
Thus, the likelihood of contracting any of the four diseases may have had a stronger 
effect due to the change in probability being larger than any difference in negative utility 
associated between the different illnesses.   
Implications for multi-attribute decision making 
The current findings suggest that participants were sensitive to changes in the task 
environment, incorporated multiple decision-making strategies, and generally responded 
to prevalence such that higher prevalence of illness was associated with spending more 
time attending to benefits and less to costs and making choices that prioritized higher 
benefits at the expense of cost. These results support the idea that elements of the task 
environment can influence decision processes and outcomes.  Payne and Bettman (2004) 
discussed the impact that task environment can have on decision processes, such as task 
complexity or time constraints leading to individuals switching from a more 
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comprehensive processing strategy to a heuristics-based strategy. While evidence from 
the present study suggest participants incorporate different decision strategies in response 
to a change in task environment, the variables manipulated in this study did not affect 
task complexity or time pressure. The primary purpose for the manipulation of 
seriousness and prevalence of illness was to create a task environment that could affect 
participants’ decision making and strategy selection by providing a potentially harmful 
consequence associated with the decision. 
Bettman, Luce, and Payne (1998) discussed the implications of prior research on 
adaptive decision-making and how individuals adapt decision strategies based on changes 
in the task environment.  They conclude that deploying multiple strategies, including 
more logical controlled evaluative strategies and heuristics-based strategies, can be 
beneficial to people in a consumer context. The authors also identify topics for future 
research on choice.  One particular topic concerns decision-making involving the 
minimization of negative emotion. These scenarios may involve decisions where a trade-
off involves an unwanted outcome, consideration of alternatives with ethical or moral 
implications, or the potential that a decision may yield an immediate benefit followed by 
some unwanted consequence associated with the decision in the future.  Specifically, the 
authors suggested that emotion-laden decision scenarios would likely lead to higher 
attribute-focused processing with specific attention given to attributes that allow the 
individual to avoid negative consequences.  The present study provides unique data that 
addresses this need in research. The scenarios provided outcomes where the primary goal 
is to avoid a negative event, where the method of reducing the likelihood of experiencing 
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the event is by making a decision regarding a vaccine that includes both costs and 
benefits associated with the attributes.  The results from the present study support the 
assumption that an emotionally-laden decision would result in more selective processing 
that may result in sacrificing costs within some attributes in order to maximize the 
benefits, thus, minimizing the negative emotion potentially experienced after the decision 
is made.   
Not all aspects of the task environment in the present study led to adaptive 
decision-making that would support the concept of adaptation to reduce potential for 
negative outcomes.  Seriousness of illness had a moderate effect on decision outcomes in 
the hypothesized direction, but this aspect of the task environment had no effect on 
strategy selection. Participants were much more sensitive to changes in prevalence than 
they were to seriousness, despite survey responses indicating that participants perceived 
flu and mumps as lower in seriousness, while meningitis and typhoid fever were 
perceived as higher in seriousness. Based on the assumption that emotion-laden choices 
would result in adaptive decision-making to focus on attributes that would reduce the 
negative consequences, it would seem that both prevalence and seriousness of illness 
would have this effect. 
One potential explanation for the discrepancy in effect sizes for seriousness and 
prevalence could be that seriousness of illness had descriptions that were absolute in 
nature: Each disease had clear symptoms associated with them.  Appendix A shows the 
descriptions of each of the eight scenarios.  In each, the disease includes descriptions of 
symptoms associated with them. The prevalence manipulation was much more 
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probabilistic in nature, as was intended.  However, participants may have approached this 
uncertainty with more caution and therefore were more likely to adapt their decisions to 
favor vaccines that would reduce the likelihood of contracting the diseases. For instance, 
the low prevalence meningitis scenario mentions meningitis outbreaks in the country, but 
not locally. The early symptoms of meningitis are then provided including stiff neck, 
vomiting, sensitivity to light, with additional information stating that meningitis can be 
fatal if left untreated. The high prevalence scenario, conversely, specifies that an outbreak 
is suspected locally for meningitis. Participants may have interpreted the low prevalence 
scenario as a near certainty that meningitis would not be a concern, and the high 
prevalence scenario as a much more immediate cause for concern.  Unfortunately, 
prevalence was manipulated primarily by using language from sample CDC reports and a 
manipulation check was not conducted for this variable.  Additionally, the manipulation 
of prevalence was done with the purpose of minimizing the frequencies used to describe 
the attributes with probabilistic values (e.g., Effectiveness of vaccine = 1/100 people still 
get meningitis after receiving vaccine).  The goal with the manipulation was to 
communicate that prevalence was probabilistic, but not one that required complex 
computations using the information provided with the vaccine attributes.  
Implications in health domain 
The results from this study could have implications regarding how people 
perceive general health risks and, potentially, how health risks may be best 
communicated to individuals, how to increase compliance with vaccinations, and how to 
increase general understanding regarding the potential threats related to outbreaks of 
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diseases.  As noted, one of the more interesting findings in the study was the way 
prevalence of disease influenced decision-making strategies and overall choice more than 
the seriousness of the illness.   
The illnesses used in the study ranged from a perception of relatively low concern 
to severely debilitating, both in the severity of symptoms associated with the disease and 
the perception of the effect of these symptoms on participants.  Despite this, participants 
were not as likely to change their decision strategies or choose the most effective vaccine 
as when information was provided in the scenarios that indicated the immediacy of the 
risk associated with prevalence in the environment.  These findings could be used to aid 
in the communication and education of potential risks associated with illnesses.  For 
instance, current information regarding the flu available at the Centers for Disease 
Control and Prevention’s (CDC, 2017) website presents the importance of getting a flu 
vaccination based largely on the complications associated with flu symptoms. The current 
findings suggest that framing the importance of receiving a flu vaccination in terms of the 
prevalence of the virus may be more effective at ensuring compliance than framing the 
importance by discussing the effects of the disease. Information regarding the adverse 
effects of influenza should clearly still be available, but highlighting the importance of 
the vaccine by communicating the prevalence of the illness in a given flu season may aid 
in the compliance of individuals with receiving the vaccine.  
Limitations 
While the present provides additional insights into how decision-making 
processes and outcomes may be affected by multi-attribute decision-making scenarios 
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that involve applications of negative utility, there are areas that could be improved in 
future studies. 
Generalizability.  While many efforts were made to ensure the strength of the 
manipulation with regard to its effect on negative utility, there is still a difference in a 
hypothetical description of the probability and negative utility of an event and an actual 
event involving disease outbreaks or prevalence associated with travel to other countries.  
Participants read and responded to the scenarios as if they were true, but knowledge of 
the scenarios could have a different impact than what was observed. This could be 
observed in the relatively large effect of prevalence on decision making in the study. The 
Centers for Disease Control and Prevention (CDC, 2017) found that despite whether a flu 
season is reported as being more or less problematic for a given year, vaccine coverage 
has remained the same since 2010 and seems to vary more due to vaccine shortages than 
information regarding the prevalence of influenza for a given year. 
The current study also provided a decision-making context involving a forced-
choice.  Essentially, each scenario was presented with four vaccine choices.  However, 
participants never had the option to navigate to the next scenario without choosing one of 
the four available alternatives.  As such, situations in which a participant would choose 
not to receive a vaccination were not included as a part of this study.  As part of the post-
test questionnaire, participants were asked about their estimated history regarding flu 
vaccination.  Responses from this question indicated that all of the participants in the 
study had been vaccinated in past flu seasons, and that none of the participants selected 
the option that they never get vaccinated for the flu.  This question was asked regarding 
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the flu vaccine, which is typically available from year to year.  However, vaccinations 
due to diseases that have been associated with localized outbreaks or travel to specific 
countries were not included in the questionnaire due to the fact that many participants in 
the study would likely not have experienced these specific circumstances. 
Conclusion 
Despite limitations involving the health-care context and the specifics of the 
manipulations of seriousness and prevalence, this study provided further evidence of 
scenarios that can influence decision-making and how people may adapt their decision-
making by using different strategies to evaluate decision attributes and alternatives. 
While individual differences exist regarding overall strategy use in decision-making 
within the context studied, there were still notable overall effects of prevalence and 
seriousness of an illness on the decisions of participants, and on what strategies were 
used to evaluate the decision alternatives provided. Future studies could build on this 
study by deploying different methodologies to capture the decision-making processes 
(e.g, eye-tracking methods), or focusing on the application of these results in 





Scenarios for each combination of seriousness and prevalence 
Low prevalence – Flu 
Headline: 2018 Flu Season Expected to be Mild on Campus 
Flu season is in full swing, and local health officials say the effect in Clemson University 
and statewide has been mild compared to previous years. 
In the past week, the number of flu patients hospitalized in Clemson has been at the 
lowest in 10 years. The number of students who have received vaccinations this year is 
also very high, indicating that the likelihood of a rapid increase in individuals contracting 
the influenza virus is very low. 
Many professors and instructors have also commented on the sharp decrease in students 
missing classes due to influenza. 
Despite the mild flu season, a flu vaccination is still recommended. While it is not as 
urgent, supplies of the vaccination are high and students will have many different options 
to choose from that can protect against any potential increase in the number of people 
who report getting the flu. 
Low prevalence – Mumps 
Headline: Clemson University Officials Not Concerned Regarding Mumps Outbreak 
While three campuses in the US have reported on-campus mumps outbreaks, Clemson 
University is not expected to be as vulnerable according to officials. 
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Due to the high proportion of students who have documented mumps immunizations that 
protect against the particular strains that have been detected, and high turnout for flu 
vaccinations, the chance of mumps spreading to the degree of a large-scale outbreak is 
very slim. 
Officials caution that mumps can lead to hospitalization and potentially be fatal if left 
unmanaged, with early symptoms such as swelling of salivary glands, nausea, dry mouth, 
and in serious cases loss of voice. If not caught, mumps can cause organ failure and in 
rare cases, infertility. 
However, outbreaks of mumps are extremely rare. Nevertheless, MMR booster 
vaccinations are available and are required for additional strains of mumps. Students will 
have a choice of which booster they would like to receive. 
Low prevalence – Typhoid 
Headline: Traveler’s Notice Regarding Risk of Typhoid in Australia 
Despite the increasing trend of travelers contracting Typhoid Fever in various countries, 
individuals planning a trip to Australia and/or New Zealand, region officials state that 
there is very little risk of contracting the bacterial disease. 
Typhoid fever is a systemic disease of varying severity, with common symptoms being 
high fever, nausea, fatigue, extreme loss of appetite, and insomnia. Without treatment, 
patients may develop gastrointestinal infections, pneumonia, and may become chronic 
carriers of the disease. Typhoid fever is spread through consumption of food and water. 
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If you are planning to travel to any of these countries*, the risk of contracting Typhoid 
Fever is very low. However, doctors still suggest considering taking the vaccine booster 
as a precaution. 
*Note: In this example, you are planning to travel to Australia for six months.
Low prevalence – Meningitis 
Headline: Clemson University Officials Not Concerned Regarding Meningitis Outbreak 
While two campuses in the US have reported local meningitis outbreaks, Clemson 
University is not expected to be as vulnerable according to officials. 
Due to the large number of students who have up-to-date meningitis vaccination records 
and have turned out across campus for flu vaccinations, the chance of meningitis 
spreading to the degree of a large-scale outbreak is very slim. 
Officials remind that meningitis is a very serious disease that can lead to hospitalization 
and potentially be fatal, with early symptoms such as stiff neck, vomiting, and sensitivity 
to light. If not caught, meningitis can lead to gangrene, possibly requiring amputation. 
However, outbreaks of meningitis are extremely rare. Nevertheless, booster vaccinations 
are available and are required for additional strains of bacterial meningitis. Students will 
have a choice of which booster they would like to receive. 
High prevalence – Flu 
Headline: 2018 Flu Season Expected to be Severe on Campus 
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Flu season is in full swing, and local health officials say the effect in Clemson University 
and statewide has been severe compared to previous years. 
In the past week, the number of flu patients hospitalized in Clemson has been at the 
highest in 10 years. Those who have been hospitalized have reported particularly severe 
symptoms, including high-grade fevers, respiratory issues, pneumonia, and in some cases 
kidney failure. These symptoms have had a quick onset as well, compared to many 
strains of the flu that have been detected in the past. 
Professors and instructors have reported many students missing classes with excuses 
from doctors regarding the flu. 
Because the common strains this year are all severe, and many students are already being 
hospitalized, most officials recommend getting the flu shot as soon as possible. 
High prevalence – Mumps 
Headline: Clemson University Officials Concerned Regarding Mumps Outbreak  
While three campuses in the US have reported on-campus mumps outbreaks, Clemson 
University is not expected to be as vulnerable according to officials. 
Due to the high proportion of students who have documented mumps immunizations that 
protect against the particular strains that have been detected, and high turnout for flu 
vaccinations, the chance of mumps spreading to the degree of a large-scale outbreak is 
very slim. 
Officials caution that mumps can lead to hospitalization and potentially be fatal if left 
unmanaged, with early symptoms such as swelling of salivary glands, nausea, dry mouth, 
70
and in serious cases loss of voice. If not caught, mumps can cause organ failure and in 
rare cases, infertility. 
However, outbreaks of mumps are extremely rare. Nevertheless, MMR booster 
vaccinations are available and are required for additional strains of mumps. Students will 
have a choice of which booster they would like to receive. 
High prevalence – Typhoid 
Headline: Traveler’s Notice Regarding Risk of Typhoid in Southeast Asia  
For individuals planning a trip to Thailand, Laos, Vietnam, Indonesia, and other areas in 
south Asia, officials are warning of an increase in reported cases of Typhoid Fever in 
both animals and humans in the regions. 
Typhoid fever is a systemic disease of varying severity, with common symptoms being 
high fever, nausea, fatigue, extreme loss of appetite, and insomnia. Without treatment, 
patients may develop gastrointestinal infections, pneumonia, and may become chronic 
carriers of the disease. Typhoid fever is spread through consumption of food and water. 
If you are planning to travel to any of these countries*, it is highly advised you take one 
of the four new vaccine boosters available. 
*Note: In this example, you are planning to travel to Thailand for six months.
 High prevalence – Meningitis 
Headline: Clemson University Officials Concerned Regarding Meningitis Outbreak 
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This season, two campuses in the US have reported local meningitis outbreaks. Clemson 
University now makes a third. 
Due to the fact that many students have not received the booster vaccine in addition to 
their standard required vaccines, the chance of meningitis spreading to the degree of a 
large-scale local outbreak is increasing. 
Officials remind that meningitis is a very serious disease that can lead to hospitalization 
and potentially be fatal, with early symptoms such as stiff neck, vomiting, and sensitivity 
to light. If not caught, meningitis can lead to gangrene, possibly requiring amputation. 
Additionally, meningitis can be transmitted quite easily. People can be carriers for the 
disease and never exhibit symptoms. 
Booster vaccinations are available and are required for additional strains of bacterial 
meningitis. Students will have a choice of which booster they would like to receive. 
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Appendix B 
DOSPERT HEALTH AND SAFETY QUESTIONNAIRE 
People often see some risk in situations that contain uncertainty about what the outcome 
or consequences will be and for which there is the possibility of negative consequences. 
However, riskiness is a very personal and intuitive notion, and we are interested in your 
gut level assessment of how risky each situation or behavior is. 
1.) Giving blood 
1 2 3 4 5 6 7 












2.) Participating in a clinical trial to determine whether a new drug is effective 
1 2 3 4 5 6 7 












3.) Taking daily medication in preparation for allergies 
1 2 3 4 5 6 7 












4.) Getting knee replacement surgery to treat arthritis 
1 2 3 4 5 6 7 












5.) Receiving general rather than local anesthesia when having a wisdom tooth 
removed 
1 2 3 4 5 6 7 












6.) Drinking heavily at a social function 
1 2 3 4 5 6 7 
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7.) Driving a car without wearing a seatbelt 
1 2 3 4 5 6 7 












8.) Riding a motorcycle without a helmet 
1 2 3 4 5 6 7 












9.) Walking home alone in an unsafe area of town 
1 2 3 4 5 6 7 












10.) Sunbathing without sunscreen. 
1 2 3 4 5 6 7 














Seriousness of illness manipulation check 
Please rate using the 1 to 7 scale below your response of, in general, how afraid you 
would be of getting: 
1.) The Flu 
1 2 3 4 5 6 7 












2.) The Mumps 
1 2 3 4 5 6 7 













1 2 3 4 5 6 7 












4.) Typhoid Fever 
1 2 3 4 5 6 7 













For each of the diseases below, please rate using the 1 to 7 scale your perception of how 
bad it would be (in terms of debilitation, amount of time spent in recovery, and risk 
to long-term health) if you were diagnosed with: 
1.) Flu 













2.) The Mumps 



























4.) Typhoid Fever 
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